| Agonists of proteinase-activated receptor 2 induce inflammation by a neurogenic mechanism M Steinhoff, N Vergnolle, SH Young, M Tognetto, S Amadesi, HS Ennes, ... Nature medicine 6 (2), 151-158, 2000 | 1128 | 2000 |
| NSAID-induced gastric damage in rats: requirement for inhibition of both cyclooxygenase 1 and 2 JL Wallace, W McKnight, BK Reuter, N Vergnolle Gastroenterology 119 (3), 706-714, 2000 | 927 | 2000 |
| Role for protease activity in visceral pain in irritable bowel syndrome N Cenac, CN Andrews, M Holzhausen, K Chapman, G Cottrell, ... The Journal of clinical investigation 117 (3), 636-647, 2007 | 715 | 2007 |
| Proteinase-activated receptors: transducers of proteinase-mediated signaling in inflammation and immune response M Steinhoff, J Buddenkotte, V Shpacovitch, A Rattenholl, C Moormann, ... Endocrine reviews 26 (1), 1-43, 2005 | 627 | 2005 |
| Proteinase-activated receptor-2 and hyperalgesia: a novel pain pathway N Vergnolle, NW Bunnett, KA Sharkey, V Brussee, SJ Compton, EF Grady, ... Nature medicine 7 (7), 821-826, 2001 | 567 | 2001 |
| Protease-activated receptor 2 sensitizes the capsaicin receptor transient receptor potential vanilloid receptor 1 to induce hyperalgesia S Amadesi, J Nie, N Vergnolle, GS Cottrell, EF Grady, M Trevisani, ... Journal of Neuroscience 24 (18), 4300-4312, 2004 | 501 | 2004 |
| Induction of intestinal inflammation in mouse by activation of proteinase-activated receptor-2 N Cenac, AM Coelho, C Nguyen, S Compton, P Andrade-Gordon, ... The American journal of pathology 161 (5), 1903-1915, 2002 | 450 | 2002 |
| Protease‐activated receptor 2 sensitizes the transient receptor potential vanilloid 4 ion channel to cause mechanical hyperalgesia in mice AD Grant, GS Cottrell, S Amadesi, M Trevisani, P Nicoletti, S Materazzi, ... The Journal of physiology 578 (3), 715-733, 2007 | 446 | 2007 |
| Protease-activated receptors in inflammation, neuronal signaling and pain N Vergnolle, JL Wallace, NW Bunnett, MD Hollenberg Trends in pharmacological sciences 22 (3), 146-152, 2001 | 440 | 2001 |
| Planning experiments: Updated guidance on experimental design and analysis and their reporting III MJ Curtis, SPH Alexander, G Cirino, CH George, DA Kendall, PA Insel, ... British Journal of Pharmacology 179 (15), 3907-3913, 2022 | 402 | 2022 |
| The intestinal microenvironment and functional gastrointestinal disorders G Barbara, C Feinle-Bisset, UC Ghoshal, J Santos, SJ Vanner, ... Gastroenterology 150 (6), 1305-1318. e8, 2016 | 387 | 2016 |
| Protease‐activated receptor 2 sensitizes TRPV1 by protein kinase Cɛ‐and A‐dependent mechanisms in rats and mice S Amadesi, GS Cottrell, L Divino, K Chapman, EF Grady, F Bautista, ... The Journal of physiology 575 (2), 555-571, 2006 | 332 | 2006 |
| Proteinase-activated receptor-2-activating peptides induce leukocyte rolling, adhesion, and extravasation in vivo N Vergnolle The Journal of Immunology 163 (9), 5064-5069, 1999 | 272 | 1999 |
| Food-grade bacteria expressing elafin protect against inflammation and restore colon homeostasis JP Motta, LG Bermúdez-Humarán, C Deraison, L Martin, C Rolland, ... Science translational medicine 4 (158), 158ra144-158ra144, 2012 | 269 | 2012 |
| Characterization of the inflammatory response to proteinase‐activated receptor‐2 (PAR2)‐activating peptides in the rat paw N Vergnolle, MD Hollenberg, KA Sharkey, JL Wallace British journal of pharmacology 127 (5), 1083-1090, 1999 | 264 | 1999 |
| Proteinases and proteinase-activated receptor 2: a possible role to promote visceral hyperalgesia in rats AM Coelho, N Vergnolle, B Guiard, J Fioramonti, L Bueno Gastroenterology 122 (4), 1035-1047, 2002 | 260 | 2002 |
| Proteinase-activated receptor 2 is an anti-inflammatory signal for colonic lamina propria lymphocytes in a mouse model of colitis S Fiorucci, A Mencarelli, B Palazzetti, E Distrutti, N Vergnolle, ... Proceedings of the National Academy of Sciences 98 (24), 13936-13941, 2001 | 250 | 2001 |
| Gastrointestinal biofilms in health and disease JP Motta, JL Wallace, AG Buret, C Deraison, N Vergnolle Nature Reviews Gastroenterology & Hepatology 18 (5), 314-334, 2021 | 227 | 2021 |
| Protease inhibition as new therapeutic strategy for GI diseases N Vergnolle Gut 65 (7), 1215-1224, 2016 | 227 | 2016 |
| Clinical relevance of proteinase activated receptors (pars) in the gut N Vergnolle Gut 54 (6), 867-874, 2005 | 214 | 2005 |